Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_540eec52930b35c22108814088f97cb9 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 |
filingDate |
2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_586ed5d6e99ba5e5912632a52f1ab815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98beb695e6121d3938e81f7233290b51 |
publicationDate |
2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2012258439-A1 |
titleOfInvention |
Prolyl hydroxylase inhibitors |
abstract |
C:\NRPortbI\DCC\SXD\4782176 _.DOC-30/1/2012 The invention described herein relates to certain quinoxaline-5-carboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases 5 benefiting from the inhibition of this enzyme, anemia being one example. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110981819-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110981819-B |
priorityDate |
2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |